Philippines

Philippines

HBV elimination goal
No
Year of HBV elimination goal
No data
HBV Action Plan
Out of Date
HCV elimination goal
No
Year of HCV elimination goal
No data
HCV Action Plan
Yes
Prevalence
Prevalence of chronic HBV (HBsAg+) (%)
8.24
2019 , Survey/reported
Minta , A. A., Silva, M. W. T., Shrestha, A., et al.,(2021). Hepatitis B Surface Antigen Seroprevalence Among Children in the Philippines. Vaccine; 39(14), pp. 1982-1989.
Prevalence of chronic HBV (HBsAg+), Children < 5 yrs
No data
Prevalence
Prevalence of chronic HCV (RNA+/cAg) (%)
0.58
2017 , Modelled
Ong, J.P., Lam, H. (2018). Ending the Silent Epidemic of Chronic Hepatitis in the Philippines: Establishing the Burden of Hepatitis in the Philippines. WHO Western Pacific Regional Office, Center for Disease Analysis Foundation, approved PCHRD.
Prevalence of chronic HCV (RNA+/cAg), Persons who inject drugs
No data
Mortality
HBV-related death rate (per 100,000)
5.4
2019 , Modelled
(4 - 6)
Institute of Health Metrics and Evaluation (IHME). Global burden of Disease Study 2019
Mortality
HCV-related death rate (per 100,000)
4.56
2019 , Modelled
(3 - 5)
Institute of Health Metrics and Evaluation (IHME). Global burden of Disease Study 2019
Diagnosed & treated
Proportion of persons living with HBV diagnosed (%)
11
2022 , Modelled
Razavi-Shearer D, Gamkrelidze I, Pan C, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. The Lancet Gastroenterology & Hepatology. 2023;8(10):879-907. doi:10.1016/S2468-1253(23)00197-8
Proportion of diagnosed persons receiving appropriate HBV treatment (%) (among those eligible)
No data
Diagnosed & treated
Proportion of persons living with HCV diagnosed (%)
No data
Proportion of diagnosed persons who have initiated HCV treatment (%)
No data
HepB newborn vaccination
Coverage of HepB birth dose (%)
53
2022 , Survey/reported
WHO/UNICEF Joint Reporting Form on Immunization (JRF), Last Accessed 24 January 2024
Harm reduction
Number of needles-syringes per PWID per year
No data
Key policy indicators
HBV screening recommendations for pregnant women
Adopted
No patient co-pays for HBsAg testing
Adopted
Key policy indicators
National policy for harm reduction for persons who inject drugs
Not Adopted
No patient co-pays for anti-HCV testing
Not Adopted
Simplified HCV care: Non-specialists can prescribe treatment
Adopted
Year Value Type Source
Equity
Indicator Status Notes
Decriminalization of drug use Not Adopted
Philippines National Hepatitis Elimination Profile
National anti-discrimination law protecting persons living with hepatitis Not Adopted
Philippines National Hepatitis Elimination Profile
National policy for adult HBV vaccination Adopted
Philippines National Hepatitis Elimination Profile
National policy for harm reduction for persons who inject drugs Not Adopted
Philippines National Hepatitis Elimination Profile
National policy for syringe exchange in federal prisons Not Adopted
Philippines National Hepatitis Elimination Profile
National strategy addresses key populations Adopted
Philippines National Hepatitis Elimination Profile
Prevention of mother-to-child transmission
Indicator Status Notes
Elimination of HBV mother to child transmission goal Yes
Philipinnes National Hepatitis Elimination Profile
HBV screening recommendations for pregnant women Adopted
Philippines National Hepatitis Elimination Profile
Universal HepB birth dose policy within 24 hrs of birth Adopted
Philippines National Hepatitis Elimination Profile
Strategic information
Indicator Status Notes
Estimates of HBV economic burden Not Adopted
Philipinnes National Hepatitis Elimination Profile
National HBV prevalence survey within last 5 years Not Adopted
Philippines National Hepatitis Elimination Profile
Routine official reporting of HBV incidence Not Adopted
Philippines National Hepatitis Elimination Profile
Routine official reporting of HBV mortality Not Adopted
Philippines National Hepatitis Elimination Profile
System to monitor HBV diagnosis and treatment Not Adopted
Philippines National Hepatitis Elimination Profile
Financing
Indicator Status Notes
GFTAM funds used for HBV and/or HCV testing and treatment or harm reduction Adopted
Philipinnes National Hepatitis Elimination Profile
Public budget line for HBV testing and treatment Not Adopted
Philippines National Hepatitis Elimination Profile
National planning
Indicator Status Notes
HBV Action Plan Out of Date
Philipinnes National Hepatitis Elimination Profile
HBV elimination goal No
Philipinnes National Hepatitis Elimination Profile
Screening
Indicator Status Notes
HBV age-based or birth-cohort screening recommendations Not Applicable
Philippines National Hepatitis Elimination Profile
HBV risk-based screening recommendations Adopted
Philippines National Hepatitis Elimination Profile
HBV universal screening recommendations Partially Adopted
Philippines National Hepatitis Elimination Profile
No patient co-pays for HBsAg testing Adopted
Philipinnes National Hepatitis Elimination Profile
Access to testing and medicines
Indicator Status Notes
Licensed point-of-care PCR testing to detect HBV Adopted
Philipinnes National Hepatitis Elimination Profile
Treatment
Indicator Status Notes
National HBV treatment guidelines Developed
Philipinnes National Hepatitis Elimination Profile
Simplified HBV care: No treatment co-pays Not Adopted
Philippines National Hepatitis Elimination Profile
Simplified HBV care: Treatment and monitoring algorithm for primary care providers Adopted
Philippines National Hepatitis Elimination Profile
Year Value Type Source
Year Value Type Source
Equity
Indicator Status Notes
Decriminalization of drug use Not Adopted
Philippines National Hepatitis Elimination Profile
Decriminalization of possession of syringes and paraphernalia Not Adopted
Philippines National Hepatitis Elimination Profile
National anti-discrimination law protecting persons living with hepatitis Not Adopted
Philippines National Hepatitis Elimination Profile
National policy for harm reduction for persons who inject drugs Not Adopted
Philippines National Hepatitis Elimination Profile
National policy for syringe exchange in federal prisons Not Adopted
Philippines National Hepatitis Elimination Profile
National strategy addresses key populations Adopted
Philippines National Hepatitis Elimination Profile
Access to testing and medicines
Indicator Status Notes
Eligible for HCV generic medicines Eligible
Philippines National Hepatitis Elimination Profile
Licensed point-of-care PCR testing to detect HCV Adopted
Philippines National Hepatitis Elimination Profile
Registration of HCV generic medicines Adopted
Philippines National Hepatitis Elimination Profile
Registration of HCV originator medicines Adopted
Philippines National Hepatitis Elimination Profile
Strategic information
Indicator Status Notes
Estimates of HCV economic burden Not Adopted
Philippines National Hepatitis Elimination Profile
National HCV prevalence survey within last 5 years Not Adopted
Philippines National Hepatitis Elimination Profile
Routine official reporting of HCV incidence Not Adopted
Philippines National Hepatitis Elimination Profile
Routine official reporting of HCV mortality Not Adopted
Philippines National Hepatitis Elimination Profile
System to monitor HCV diagnosis and treatment Not Adopted
Philippines National Hepatitis Elimination Profile
Financing
Indicator Status Notes
GFTAM funds used for HBV and/or HCV testing and treatment or harm reduction Adopted
Philipinnes National Hepatitis Elimination Profile
Public budget line for HCV testing and treatment Not Adopted
Philippines National Hepatitis Elimination Profile
National planning
Indicator Status Notes
HCV Action Plan Yes
Philippines National Hepatitis Elimination Profile
HCV elimination goal No
Philippines National Hepatitis Elimination Profile
Screening
Indicator Status Notes
HCV age-cohort or birth-cohort screening recommendations Not Adopted
Philippines National Hepatitis Elimination Profile
HCV risk-based screening recommendations Adopted
Philippines National Hepatitis Elimination Profile
HCV universal screening recommendations Not Adopted
Philippines National Hepatitis Elimination Profile
No patient co-pays for anti-HCV testing Not Adopted
Philippines National Hepatitis Elimination Profile
Prevention of mother-to-child transmission
Indicator Status Notes
HCV screening recommendations for pregnant women Adopted
Philippines National Hepatitis Elimination Profile
Treatment
Indicator Status Notes
National HCV treatment guidelines Developed
Philippines National Hepatitis Elimination Profile
Simplified HCV care: Less than 2 clinic visits during treatment Partially Adopted
Philippines National Hepatitis Elimination Profile
Simplified HCV care: No fibrosis restrictions Adopted
Philippines National Hepatitis Elimination Profile
Simplified HCV care: No genotyping requirements Adopted
Philippines National Hepatitis Elimination Profile
Simplified HCV care: No sobriety restrictions Not Adopted
Philippines National Hepatitis Elimination Profile
Simplified HCV care: No treatment co-pays Not Adopted
Philippines National Hepatitis Elimination Profile
Simplified HCV care: Non-specialists can prescribe treatment Adopted
Philippines National Hepatitis Elimination Profile
Year Value Type Source
Page last updated: 19 January 2024